Sana Biotechnology's total assets for Q1 2026 were $373.59M, a decrease of -10.39% from the previous quarter. SANA total liabilities were $254.35M for the fiscal quarter, a -0.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.